CF AMR Syndicate's Funding Call for Antimicrobial Innovators

The CF AMR Syndicate will be hosting a webinar officially launching a £3 million Collaborative Discovery funding call aimed at accelerating the development of new antimicrobials for people living with Cystic Fibrosis. This live webinar will be broadcast on 30th March 2023, 14:00 – 15:00 BST. To register your attendance visit our website: www.cfamr.org.uk

The session’s talks will cover living with CF, the need for new antimicrobials and the criteria new antimicrobials need to meet in order to fulfil patient and clinical needs. We will also give an overview of our upcoming funding call. The agenda for the webinar is as below:

• Opening Remarks and Introduction to the CF AMR Syndicate – Dr. Katy Kettleborough & Dr Paula Sommer
• Living with CF – A Personal Perspective – Angelo Micciche (previously recorded video)
• The need for new antimicrobials in CF & what good looks like – Target Product Profiles – Prof. Jane Dav
• The Collaborative Discovery Programme: Funding Call Overview – Dr. Neill Gingles & Dr. Ed McIver
• Interactive Q&A – CF AMR Syndicate Management Team

We are looking to provide funding and support to drug discovery projects that address the needs and priorities of people with CF as set out in the CF AMR Syndicate’s recently published Target Product Profiles for Antimicrobials (Request your free copy via our website). Further detail on the funding call will be available on our website immediately following the webinar – with expressions of interest open until 9th May 00:00 BST.

Free